Retroperitoneal Inflammatory Myofibroblastic Tumor: Case Report and Immunohistochemistry Study

Inflammatory myofibroblastic tumors (IMT) are a rare clinicopathological entity of yet unknown etiology and those located retroperitoneally are even rarer. Clinical outcome is unpredictable and complete surgical resection of the tumor remains the principal treatment. We report the case of a 41-year...

Descripción completa

Detalles Bibliográficos
Autores principales: Ziadi, Sonia, Trimeche, Mounir, Mestiri, Sarra, Joma, Wafa, Mokni, Moncef, Lataif, Rached, Sriha, Badreddine, Korbi, Sadok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2010
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5649911/
https://www.ncbi.nlm.nih.gov/pubmed/29147187
http://dx.doi.org/10.4021/wjon2010.03.192w
Descripción
Sumario:Inflammatory myofibroblastic tumors (IMT) are a rare clinicopathological entity of yet unknown etiology and those located retroperitoneally are even rarer. Clinical outcome is unpredictable and complete surgical resection of the tumor remains the principal treatment. We report the case of a 41-year old man presented with abdominal pain. An abdominal magnetic resonance imaging scan revealed a retroperitoneal tumor located between the pancreas, stomach small curvature and big vessels. A laparotomy with biopsy was performed because the tumor was not amenable to surgical resection. Histopathological examination concluded to an IMT with overexpression of protein p53. Epstein-Barr virus and Human Herpesvirus-8 investigation was negative. Postoperative outcome was unfavorable.

Ejemplares similares